WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Be a Champion! Comprehensive School Physical Activity Program

Not Applicable

Completed

Conditions: Motor Activity

Interventions: Behavioral: CSPAP

First Posted Date: 2015-06-08

Last Posted Date: 2018-11-14

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 599

Registration Number: NCT02465372

Locations: 🇺🇸
Justin B. Moore, Columbia, South Carolina, United States

Systemic Steroids for Peripheral Nerve Blocks

Phase 4

Completed

Conditions: Osteoarthritis, Hip

Interventions: Drug: Dexamethasone
Drug: Bupivacaine
Drug: Epinephrine
Procedure: Lumbar Plexus Nerve Block
Drug: Saline

First Posted Date: 2015-06-08

Last Posted Date: 2018-08-31

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 115

Registration Number: NCT02464176

Locations: 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

Macronutrient Effects on Alzheimer's Disease (MEAL-2)

Not Applicable

Completed

Conditions: Insulin Resistance
Mild Cognitive Impairment
Middle Age
Prehypertension
Prediabetic State

Interventions: Other: High Diet
Other: Low Diet

First Posted Date: 2015-06-04

Last Posted Date: 2018-08-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT02463084

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart

Phase 1

Completed

Conditions: Mild Cognitive Impairment
Alzheimer's Disease

Interventions: Drug: Placebo
Drug: Insulin aspart

First Posted Date: 2015-06-03

Last Posted Date: 2020-05-12

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 24

Registration Number: NCT02462161

Locations: 🇺🇸
Wake Forest Baptist Hospital, Winston-Salem, North Carolina, United States

Perineural Steroids for Peripheral Nerve Blocks

Phase 4

Completed

Conditions: Osteoarthritis, Knee

Interventions: Drug: Dexamethasone
Drug: Bupivacaine
Drug: Epinephrine
Procedure: Saphenous Peripheral Nerve Block

First Posted Date: 2015-06-03

Last Posted Date: 2018-09-24

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 85

Registration Number: NCT02462148

Locations: 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

A Pilot Study to Examine the Effects of Vitamin D Supplementation on Mitochondrial Bioenergetics in Older Adults

Early Phase 1

Completed

Conditions: Low 25-hydroxyvitamin D Concentrations

Interventions: Dietary Supplement: Vitamin D3

First Posted Date: 2015-05-15

Last Posted Date: 2018-08-15

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 15

Registration Number: NCT02445066

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University

Completed

Conditions: Malignant Neoplasm

Interventions: Other: Medical Chart Review
Other: Questionnaire Administration
Other: Survey Administration

First Posted Date: 2015-05-14

Last Posted Date: 2023-09-08

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 267

Registration Number: NCT02444754

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Plasma Cytochrome c as Biomarker of Traumatic Injury and Predictor of Outcome

Completed

Conditions: Blunt Trauma
Trauma
Blunt Injury
Accident
Multiorgan Injury

First Posted Date: 2015-05-12

Last Posted Date: 2024-10-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 12

Registration Number: NCT02440373

Locations: 🇺🇸
Advocate Lutheran General Hospital, Park Ridge, Illinois, United States

Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3

Phase 2

Completed

Conditions: Stage IV Non-Small Cell Lung Cancer

Interventions: Other: Laboratory Biomarker Analysis
Drug: Pemetrexed Disodium
Other: Quality-of-Life Assessment

First Posted Date: 2015-04-27

Last Posted Date: 2023-10-12

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 16

Registration Number: NCT02426658

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Human Prostate Tissue Model to Maintain and Study Prostate Cancer Stem Cells

Completed

Conditions: Prostate Carcinoma
Benign Prostatic Hyperplasia

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-04-24

Last Posted Date: 2021-09-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 43

Registration Number: NCT02425800

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy